Use to diagnose Bernard-Soulier syndrome or Glanzmann thrombasthenia in patients with a lifelong history of platelet-type bleeding.
Qualitative Flow Cytometry
New York DOH Approval Status
Lavender (EDTA), pink (K2 EDTA), or yellow (ACD Solution B).
Transport 4 mL whole blood. (Min: 0.1 mL)
EDTA: Ambient: 72 hours; Refrigerated: 72 hours; Frozen: Unacceptable
ACD solution B: Ambient: 72 hours; Refrigerated: Unacceptable; Frozen: Unacceptable
Refer to report.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
|Component Test Code*||Component Chart Name||LOINC|
|2013071||GPIb (CD42b) Expression|
|2013072||GPIIb/IIIa (CD41/CD61) Expression|
|2013073||Platelet Glycoprotein Expression Interp|
- Bernard-Soulier Syndrome
- Glanzmann Thrombasthenia